ホームページ Proteases -Metabolism Neprilysin

Neprilysin

Neprilysin製品

  • All (5)
  • Neprilysin阻害剤 (5)
  • 新製品
製品コード 製品名称 製品説明 文献中Selleckの製品使用例 お客様のフィードバック
S7678 Sacubitril/valsartan (LCZ696) Sacubitril/valsartan (LCZ696, Sacubitril, Valsartan), consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure. Phase 3.
Front Pharmacol, 2025, 16:1539032
J Immunother Cancer, 2024, 12(11)e009805
Ren Fail, 2024, 46(2):2392849
LCZ696-S767801H0220171107.gif
S3388 Sacubitrilat Sacubitrilat (Sac, LBQ-657) is an active inhibitor of neprilysin (NEP).
E4454 DL-Thiorphan Thiorphan (DL-3-Mercapto-2-benzylpropanoylglycine) is a selective NEP (neprilysin) inhibitor with an IC50 of 6.9 nM. It is also a potent inhibitor of enkephalinase, with antinociceptive activity.
E7186New Sacubitril Sacubitril is a potent and orally active inhibitor of NEP (neprilysin) with an IC50 of 5 nM. It exhibits the potential to treat chronic heart failure with reduced ejection fraction.
World J Gastroenterol, 2025, 31(33):109562
S4426 Sacubitril hemicalcium salt Sacubitril (AHU-377) hemicalcium salt, a component of the heart failure medicine LCZ696, is a potent inhibitor of neprilysin (neutral endopeptidase, NEP).
S7678 Sacubitril/valsartan (LCZ696) Sacubitril/valsartan (LCZ696, Sacubitril, Valsartan), consisting of valsartan and sacubitril in 1:1 molar ratio, is an orally bioavailable, dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) for hypertension and heart failure. Phase 3.
Front Pharmacol, 2025, 16:1539032
J Immunother Cancer, 2024, 12(11)e009805
Ren Fail, 2024, 46(2):2392849
 LCZ696-S767801H0220171107.gif
S3388 Sacubitrilat Sacubitrilat (Sac, LBQ-657) is an active inhibitor of neprilysin (NEP).
E4454 DL-Thiorphan Thiorphan (DL-3-Mercapto-2-benzylpropanoylglycine) is a selective NEP (neprilysin) inhibitor with an IC50 of 6.9 nM. It is also a potent inhibitor of enkephalinase, with antinociceptive activity.
E7186New Sacubitril Sacubitril is a potent and orally active inhibitor of NEP (neprilysin) with an IC50 of 5 nM. It exhibits the potential to treat chronic heart failure with reduced ejection fraction.
World J Gastroenterol, 2025, 31(33):109562
S4426 Sacubitril hemicalcium salt Sacubitril (AHU-377) hemicalcium salt, a component of the heart failure medicine LCZ696, is a potent inhibitor of neprilysin (neutral endopeptidase, NEP).
E7186New Sacubitril Sacubitril is a potent and orally active inhibitor of NEP (neprilysin) with an IC50 of 5 nM. It exhibits the potential to treat chronic heart failure with reduced ejection fraction.
World J Gastroenterol, 2025, 31(33):109562
united states